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Objective: To describe the features of infection with Scedosporium prolificans and to investigate the possibility of a 
common source of infection. 
Methods: S.prolificans caused invasive infections in four patients at Liverpool Hospital from 1994 to 1997, prompting 
a pathologic and epidemiologic investigation. Blood cultures were processed by either the BACTEC NR660 or VITAL 
systems. MIC testing was performed with Etest strips. Strain differentiation of isolates from three of the patients and 
two soil samples from the home of one of the patients was performed by allozyme electrophoresis. 
Result.: The four cases represented disseminated infections that arose during prolonged neutropenia, and progressed 
relentlessly despite treatment, including in one case high-dose liposomal amphotericin B. In two cases, VITAL blood 
culture bottles contained mycelia of S. prolificans without the reader having signaled. An autopsy was performed in 
three of the cases. Angio-invasion, tissue necrosis and multiple abscesses were found in each patient. Multiple air 
samples from the ward were negative for S. prolificans. The organism was grown from two samples of pot plant soil 
from the home of one patient. Allozyme electrophoresis performed on isolates from three cases and pot plant soil 
indicated that all strains were unrelated. Furthermore, two patients appeared to harbor at least two different strains of 
S. prolificans. 
Conclusions: S. prolificans causes disseminated infection in neutropenic patients. Antifungal treatment, including 
high-dose liposomal amphotericin B, is ineffective in overcoming these infections. Genetic techniques discriminated all 
strains and suggested that an outbreak had not occurred. Multiple strains of S. prolificans were isolated from two 
patients, indicating the possibility of mixed infections occurring. 
Key words: Antifungal agents, disease outbreaks, hyphomycetes, immunocompromised host, leukemia, microbial 
sensitivity tests, mycologic typing techniques, opportunistic infections, Scedosporiurn prolificans 
INTROOUCTION 
Scedosporium prol$cans, first described by Malloch and 
Salkin in 1984 [l], is a saprophyte found in soil and 
potted plants [2,3]. Most of the early cases represented 
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colonization [4-81, or infection complicating con- 
taminated wounds [1,7-91. Since the 1990s there have 
been increasing reports of disseminated infection with 
this organism, usually in neutropenic patients [7,10-191. 
Such infection is usually unresponsive to antlfungals, 
and is usually fatal [7,8.10-13,15-221. 
We report the isolation of Scedosporium prol$ficaru 
h r n  four inpatients of Liverpool Hospital h m  1990 
to 1997. The four cases represented disseminated in- 
fections that were rapidly fatal. All four cases occurred 
while our hospital was undergoing extensive rebuild- 
ing. The cases of disseminated disease presented herein 
illustrate the clinical, pathologic and epidemiologic 
features of infection with Scedosporium prol$cans. 
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METHODS 
Hospital setting 
All cases were inpatients of Liverpool Hospital, a 450- 
bed tertiary referral hospital. The hospital was under- 
going considerable reconstruction when the patients 
were being cared for. 
The Haematology Ward is divided into two 
sections. The first section is serviced by the hospital’s 
general air-conditioning unit, while the second section, 
the isolation area, is serviced by a dedicated air- 
conditioning system. The air pressure in the isolation 
area is positive with respect to adjacent rooms. The 
outside air passes through high-efficiency particulate air 
(HEPA) filters immediately before returning to 
individual rooms in the isolation area. All four cases 
spent their entire admissions in the isolation area. 
Processing of blood cultures 
Blood cultures from case 2 were processed using the 
BACTEC NR860 system (Becton-Dickinson, Micro- 
biology Systems, Sparks, MD, USA) and blood cultures 
from cases 2, 3 and 4 were processed using the VITAL 
system (bioMCrieux Vitek, Australia, Pty Ltd, Sydney, 
Australia). 
With both systems, bottles were removed from the 
machine, and their contents Gram-stained and sub- 
cultured onto horse blood agar, chocolate agar, and 
Sabouraud agar plates. The Sabouraud plates were 
inspected at 24 and 48 h, and then weekly for up to 3 
weeks. Fungi were identified morphologically, and 
identifications were confirmed by the reference labora- 
tory (National Mycology Reference Laboratory, Royal 
North Shore Hospital, St Leonards, Sydney, Australia). 
The reference laboratory also performed MIC testing 
using Etest strips (AB BIODISK, Solna, Sweden). 
Environmental sampling 
Air samples were collected using a Surface Air System 
Super 90 device (Extech Equipment Pty Ltd, Sydney, 
Australia). This takes in air a t  a fixed speed for a variable 
time through a laminar flow plate, over the surface of 
a 55-mm Rodac plate containing Sabouraud agar 
(without antibacterials). It was determined empirically 
that 500 L was the optimal volume of air to collect (data 
not shown). Cultures for fungi were incubated at 28OC 
for up to 2 weeks. The average number of colony- 
forming units (CFUs) present on each plate was deter- 
mined, and results per cubic meter calculated. 
Air samples were collected from all rooms in the 
isolation area over 4 months. These were collected 30 
cm from the air outlet, at the bedside, from the middle 
of the room, along the main corridor and within the fire 
stairwell. Normal nursing activities continued during 
testing. 
Eye drops from case 3 and swabs of nebulizers used 
on the ward were also cultured for fungi on Sabouraud 
agar (without antibacterials), and were incubated for 6 
weeks. 
Pot plant soil from the home of case 3 was 
processed by mixing a small amount with 10 mL of 
sterile saline and passing the suspension through a 
coarse wire filter; and 0.25 mL of amphotericin B 
solution (200 pg/L) was added, to select out Scedo- 
sporiurn prolijicans. The suspension was allowed to stand 
for 30 min and then centrifuged at 3000 rev/min for 
5 min. The sediment was cultured onto Sabouraud agar 
with chloramphenicol, and incubated at 28°C and 
37°C; cultures were examined daily. Dark colonies, 
suggestive of Scedosporirim prolijicans, were subcultured 
onto Sabouraud agar and their identity confirmed 
morphologically. 
Strain differentiation 
Isolates from cases 2, 3 and 4 and two isolates from the 
soil of pot plants from the home of case 3, were typed 
by allozyme electrophoresis at the University of 
Adelaide. Subcultures were harvested in 1 mL of Tris- 
HC1 (pH 7.5) and pelleted by centrifugation. An 
equivalent volume of lysis buffer (0.1% P-mercapto- 
ethanol and 100 mg/L NADP in 100 mL HzO) was 
added and the cells were ultrasonically disrupted. After 
centrifugation, the lysates were collected in capillary 
tubes and stored at -20°C. 
The cell lysates were subjected to electrophoresis 
on cellulose acetate (Cellogel, Chemetron, Milan, 
Spain) for 75 min at 200 V at 4°C. Fourteen enzyme 
loci exhibited sufficient staining intensity and resolution 
for interpretation: alcohol dehydrogenase (EC 1.1.1. l), 
enolase (EC 4.2.1.11), fructose-1,6-diphosphate 
phosphorylase (EC 3.1.3.1 l), glutamic-oxaloacetic 
transaminase (synonym aspartate aminotransferase) (EC 
2.6.1 .l), glucose-6-phosphate dehydrogenase (EC 
1.1.1.49), inosine dehydrogenase (EC 1.1.1.42), lactate 
dehydrogenase (EC 1.1.1.27), mannose phosphate 
isomerase (EC 5.3.1.8), nucleoside diphosphate kinase 
(EC 2.7.4.6), valine-leucine peptidase (EC 3.4.1 1 or 
EC 3.4.13), leucine-glycine-glycine peptidase (EC 
3.4.1 1 or E C  3.4.13), 6-phosphoglucose dehydro- 
genase (EC 1.1.1.441, phosphoglucomutase (EC 
2.7.5.1) and superoxide dismutase (EC 1.15.1.1). The 
enzyme loci were histochemically stained according to 
the protocols of Selander et a1 and Richardson et a1 
[23,24]. The enzyme loci were scored in order of 
increasing anodal migration, where ‘a’ was the most 
cathodally migrating allele. The resultant allelic profiles 
were statistically interpreted using the unweighted pair- 
group method of analysis (UPGMA), and a dendro- 
gram was constructed. 
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literature search 
A search of the Medline database (Clinical Information 
Access Project, New South Wales Health, http:// 
trooper.hcn.net.au/ovidweb/ovidweb.cgi) encompass- 
ing the years 1966-99 was undertaken. The search 
terms included the text words ‘scedosporium pro- 
lificans’, ‘scedosporium inflatum’, ‘voriconazole’, and 
the MeSH terms ‘triazoles’, ‘fluconazole’, ‘itraconazole’, 
‘antifungal agents’, ‘disease outbreaks’, ‘hyphomycetes’, 
‘immunocompromised host’, ‘leukemia’, ‘microbial 
sensitivity tests’, ‘mycological typing techniques’, and 
‘opportunistic infections’. Other references were found 
by searching bibliographies of the references found, and 
various textbooks [25-331. 
RESULTS 
Case 1 
A 68-year-old man presented on 1 August 1994 with 
acute myeloblastic leukemia (AML). Escherichia coli 
grew from the initial blood cultures. Despite anti- 
bacterial and amphotericin B treatment, he remained 
(a) 
febrile. Cytotoxic chemotherapy was commenced on 
10 August 1994. 
The patient remained febrile and neutropenic. On 
17 August 1994 he developed consolidation in both 
lungs, and on 25 August 1994, a purulent discharge 
developed from the right nostril. A swab of this grew 
both Scedospovium prol$cans and Aspergillus fumigatus. 
Sinus X-rays were normal. Dry retching, abdominal 
pain and confusion developed, active treatment was 
stopped, and he died on 1 September 1994. 
Blood cultures taken on 28 August 1994 yielded a 
filamentous fungus in the aerobic bottle after 3 days of 
incubation. Morphologically, the isolates resembled 
scedosporiurn prolijicans, an identification which was 
subsequently confirmed by the reference laboratory. 
The patient underwent autopsy, which revealed dis- 
seminated filamentous hngal infection. 
Case 2 
A 33-year-old woman presented with AML on 29 
March 1996. She received cytotoxic chemotherapy and 
achieved remission. A second cycle of chemotherapy 
Figure 1 (a) VITAL blood culture bottle collected from case 2 on 6 June 1996 and examined on 13 June 1996, showing 
fungal mycelia; the machine, however, had not signaled. (b) Gram stain of a blood culture broth fiom case 2, showing fungal 
elements suggestive of Scedorporiurn prolijicanr. This species was subsequently isolated from blood and cerebrospinal fluid 
samples. 
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began on 13 May 1996. On 15 May 1996, bacteremia 
with Klebsiella pneumoniae and coagulase-negative 
staphylococci occurred, and antibacterials and fluco- 
nazole were administered. The patient became neutro- 
penic, and remained febrile until 22 May 1996, when 
all antimicrobials except fluconazole were stopped. 
She remained neutropenic, and fever and mucositis 
developed on 25 May 1996. Intravenous antibacterials 
were recommenced, the fever resolved, and anti- 
infective treatment was stopped on 30 May 1996. 
The patient’s fever recurred on 3 June 1996, and 
Staphylococcus epidermidis was isolated from blood cultures. 
Pleuritic chest pain and progressive pulmonary con- 
solidation developed, and a lung scan showed perfusion 
defects in each lung. From 6 June 1996 the patient 
experienced high fevers and remained neutropenic. 
The pulmonary lesions progressed, and teicoplanin, 
imipenem and amphotericin B were administered. 
Vision in the right eye deteriorated on 11 June 
1996. Examination showed hemorrhagic chemosis, 
and retinal edema with dot hemorrhages and micro- 
aneurysms. The patient was dyspneic and confused. 
Because of clinical urgency, the blood culture 
bottles inoculated on 6 June 1996 were Gram stained 
and subcultured on 13 June 1996, although the VITAL 
machine had not signaled. These bottles contained 
obvious fungal mycelia (Figure la), and the Gram stain 
was suggestive of Scedosporium prolijicans (Figure lb). 
Liposomal amphotericin B (5 mg/kg daily intra- 
venously), amphotericin B (5 pg every fourth day by 
intraocular injection) and itraconazole (400 nig daily 
via nasogastric tube) were commenced. Subsequently, 
a dematiaceous fungus grew on subculture, and tease 
mounts suggested Scedosporium prol&ans, which was 
confirmed by the reference laboratory. The reference 
laboratory obtained the following MICs: amphotericin 
B >32 mg/L, 5-flucytosine >32 mg/L, itraconazole 
>32 mg/L, and fluconazole >32 mg/L. 
A cerebral computerized tomographic (CT) scan 
showed a maxillary sinus polyp only. Turbid, xantho- 
chromic cerebrospinal fluid (CSF) was obtained by 
lumbar puncture. The cell counts were 927X lo6 red 
cells/L, and 1000X1O6 white cells/L (90% mono- 
nuclear cells, 10% neutrophils). The protein level was 
1.14 g/L (normal range 0.15-0.45 g/L) and the glucose 
level was 1.0 mM (normal range 2.0-5.0 mM). Gram 
stain showed occasional ovoid conidia, and Scedosporium 
pvolificans grew after 3 days. 
The neutrophil count rose to 3.1 X 1O9ceUs/L on 
16 June 1996, but the retinitis progressed, and the right 
eye showed massive chemosis (Figure 2a). The patient 
became obtunded, and ventricular fibrillation occurred 
on 19 June 1996; she was resuscitated from this. A CT 
scan of the cranium showed proptosis of the right globe 
with associated pre-septa1 soft tissue swelling and 
generalized scleral thickening with contrast enhance- 
ment, a hypodense lesion anterior to the left lateral 
ventricle, and the mucosal polyp. Active treatment was 
subsequently ceased and the patient l e d .  
Autopsy revealed disseminated mycosis. There 
were multiple renal and myocardial abscesses (Figure 
2b). Fungal meningoencephalitis and endophthalmitis 
was present. Mycotic aneurysms of the basilar artery 
and branches were found (Figure 2c,d). There was an 
abscess in the medial part of the right frontal lobe. 
Necrotizing bronchopneumonia with mycetoma forma- 
tion was detected. There was extensive infiltration of 
most tissues with fimgal hyphae with conidiation. 
Case 3 
A 48-year-old woman was admitted on 21 August 1996 
with acute myelomonocytic leukemia. Intravenous 
antibacterials were administered, as she was febrile; 
however, the blood cultures were negative. Chemo- 
therapy was commenced on 23 August 1996, and 
prophylactic fluconazole and nebulized amphotericin B 
were commenced. The patient experienced high fevers 
and diarrhea on 25 August 1996, and the neutrophil 
count was 0.1 x 10’ cells/L. The fevers settled over a 
few days. 
On 2 September 1996 the patient had pain in the 
right calf and mucositis. Staphylococcus haernolyticus grew 
from the blood cultures, and vancomycin was pre- 
scribed. The patient became drowsy and confused. 
Hypotension and renal failure developed, and inotropes 
and hernodialysis were commenced. Multiple hemor- 
rhagic lesions appeared on the skin of the upper torso, 
head and neck over several minutes. The inotrope 
requirement escalated, and the patient died on 10 
September 1996. 
Blood cultures from 5 September 1996 had yielded 
a dematiaceous fungus, in addition to Staphylococcirs 
haemolyticus. Tease mounts suggested Scedosporium 
prolijicans, and this was again confirmed by the reference 
laboratory. An aspirate from a skin lesion was taken. 
This was stained with Blankophor’s stain to reveal 
branching, septate hyphae (Figure 3a). Culture of the 
aspirate yielded Scedosporium prolijicans after 3 days. The 
blood culture bottles had been removed from the 
machine prematurely, despite the machine not having 
signaled, due to the clinical urgency and suspicion of 
infection with Scedosporium prolijcans. The fluid in the 
bottles contained macroscopically visible fungal 
mycelia. Eleven of 12 blood cultures from the terminal 
phase of the infection grew Scedosporiurn prolijicans but 
the CSF was not positive. Sensitivity testing of the 
isolated strain yielded identical MIC results to those of 
case 2. 
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Figure 2 Various autopsy photographs of case 2. (a) Right eye with proptosis and hemorrhagic chemosis. (b) Multiple 
abscesses in myocardium. (c) Mycotic aneurysm of basilar artery. (d) Methenamine silver stain of basilar artery aneurysm, 
showing fungal hyphae and conidia. 
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Figure 2 continued. 
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Figure 3 (a) Blankophor’s stain of aspirate of skm lesions of case 3, showing fungal hyphae. (b) Facial appearance of case 3 at 
autopsy, showing multiple purple macules with central umbilication. 
At autopsy, multiple 5-10 mm violaceous macules 
with central umbilication were found over the trunk, 
neck and head (Figure 3b). Disseminated fungal 
invasion, very similar to case 2, and a subarachnoid 
hemorrhage were found. 
Case 4 
A 46-year-old man first presented in November 1993 
with non-Hodgkin’s lymphoma. He achieved remission 
following treatment but he subsequently relapsed and 
received chemotherapy. The final course of chemo- 
therapy, which commenced in February 1997, was 
complicated by absolute neutropenia and fever. He had 
mild oral mucositis, and Staphylococcus aureus was grown 
from blood cultures. Flucloxacillin, vancomycin and 
cefpirome were administered. 
On the sixth hospital day he developed right 
periorbital swelling and right-sided pneumonia. 
Although amphotericin B was added, he became 
hypotensive, and died on day 10. Autopsy was refused. 
Subsequent to his death, Scedosporium prolijcans was 
isolated from five blood culture bottles. The identi- 
fication was confirmed by the reference laboratory. 
Antifingal sensitivity testing gave identical MIC results 
to those of isolates from cases 2 and 3. 
infection control investigation 
The close occurrence of cases 2 and 3 prompted an 
initial inquiry into potential common sources of 
infection: a fire escape door had been propped open, 
the ward was used as a thoroughfare by healthcare 
workers, nebulizers that had been dropped on the floor 
were reused without decontamination, and cut flowers 
were present in the isolation area. 
Of the 115 air samples taken, 112 grew small 
numbers of mixed saprophytic fungi, including Peni- 
cillium spp. and Cfadosporium spp. Very small numbers 
of Aspergillus fumigatus and Alternaria spp. were also 
isolated (these fungi did not cause any infections in the 
Haematology Unit at the time). However, Scedosporium 
prolijicans was not isolated from any of the air samples. 
No fungi were isolated from the eye drops used by 
case 3 or any of the nebulizers. Cut flowers were 
removed from the ward before samples could be taken 
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from them. Interestingly, two soil samples, which were 
taken from potted plants from the home of case 3 
yielded Scedospovium prolijicans. 
With the subsequent occurrence of case 4, more 
extensive environmental investigations were under- 
taken. It was found that the ceiling in a four-bedded 
room just outside the isolation area had collapsed in 
December 1996, due to a leaking sanitizer flue. 
Velocity and pressure testing of the HEPA filters was 
undertaken by external consultants (DCE Vokes Pty 
Ltd., Sydney, Australia), who found that the filters were 
clogged and the pressure gauges inaccurate. The con- 
sultants also performed air sampling, and found no 
evidence of fungal contamination. 
Each identified potential infection control problem 
was rectified immediately. 
Strain differentiation 
Twelve of the 14  enzyme loci used in the allozyme 
electrophoretic screen were polymorphic for the eight 
isolates used in the present study. The allelic profiles 
obtained are presented in Table 1. Allelic variation 
between the isolates tested was detected at 8-73% of 
the loci examined. 
The genetic relationships derived between the 
eight isolates studied are illustrated in the dendrogram 
(Figure 4). 
Case 2 CSF 
Case 2 blood 
Case 3 skin 
Case 3 blood 
Case 4 blood 
Case 3 soil ; 
Case 3 soil 
I I I I I I I I I I I  
0 10 20 30 40 50 60 70 80 90 100 
% fixed differences 
Figure 4 Dendrogram depicting the genetic relationships 
between eight Scedosporium prolijcans isolates as determined 
by allozyme electrophoresis at 14 enzyme loci and 
processed by an unweighted pair-group method of analysis. 
m 
680 C l i n i c a l  M i c r o b i o l o g y  a n d  I n f e c t i o n ,  V o l u m e  5 N u m b e r  11 ,  N o v e m b e r  1 9 9 9  
It is likely that the observed infections were not 
due to a single outbreak. The two soil isolates were 
genetically very distinct from each other, having fixed 
differences at 73% of the 14 loci examined. Further- 
more, the two isolates from each of cases 2 and 3 
appeared to be closely related but not identical (case 2 
skin versus blood, 22% fixed differences; case 3 CSF 
versus blood, 8% fixed differences), suggesting that 
more than one strain caused their infections. Isolates 
from the three patients, while they clustered within 
each patient, differed from each other at a range of 
32-51% of the 14 loci. 
DISCUSSION 
The literature describes 73 persons from whom 
Scedosporium prolijicans has been isolated [1,4-10, 
12-22,34-461, in addition to our four cases. In 15 of 
these, the significance of isolating this species is 
doubtful [4-81. There are 19 cases of invasive disease 
reported in normal hosts [1,7-9,18,35,37,38,40,44,46], 
including 12 cases of septic arthritis and/or osteo- 
myelitis [1,7-9,18,40], and three cases of ocular 
infection related to p-irradiation ofpterygia [35,37,44]. 
There are 34 cases of invasive infection with 
Scedosporium prolijicans described in immunocompro- 
mised patients, in addition to our four. The rest of the 
discussion pertains to these 38 cases; the details are 
summarized in Table 2. 
Of the 37 cases of invasive disease in immuno- 
compromised patients where the country of origin is 
reported, 14 (including our four) came from Australia 
[7,8,13,14,18,39], and 18 came from Spain [11,12,15, 
17,21,22,43,48]. Only four of the reported cases 
occurred in children [7,12,21,39]. Of the 37 cases in 
which the underlying disorder was stated, 30 (includmg 
four in this report) had various hematologic malig- 
nancies [7,lO-19,21,36,43,45], including 15 with AML 
[7,1&12,15-18,36,45], four with acute lymphoblastic 
leukemia (ALL) [7,11,12,21], four with unspecified 
acute leukemia [43] and five with lymphoma [7,13, 
14,431. There were two cases in solid organ transplant 
patients [8,20], two cases with non-malignant con- 
ditions treated with steroids [8,18], and two cases with 
AIDS [19,41]. 
The clinical presentations of disseminated in- 
fections in the immunocompromised are remarkably 
similar. Twenty-seven patients (of 30 patients where 
this has been noted) were on broad-spectrum anti- 
bacterials when they developed fungemia [8,10-13, 
15-18,20,21,36,39,43,45]. In 23 cases it was reported 
whether or not the patient was on antifungals prior to 
the onset of the disseminated infection with Scedo- 
sporium prolijicans - 16 patients had received ampho- 
tericin B prior to the dagnosis of infection with 
Scedosporium prolijicans [8,10-13,15-18,20,43]. 
There are several common clinical manifestations 
of infection with Scedosporium prolijicans. In the 38 
presented cases, 32 patients were febrile [7,8,11-13, 
15-1 8,20,21,36,39,43,45], 24 had pulmonary involve- 
ment [8,11-13,15-21,36,43,45], and 12 had neurologic 
manifestations [7,12,15,18,21,36,39,45]. Seven patients 
had muscle involvement [7,13,15-17,361. Six patients 
had ophthalmic manifestations [7,11,16,36], and six 
developed renal insufficiency [10,11,15,20,43]. Nine 
cases exhibited red to violet nodular skin lesions 
[7,13,15-17,36,39,45]. In our case 3, the skin lesions 
were remarkable for their speed of onset. The diagnosis 
was made at or after death in eight cases and before 
death in 10 of 16 cases where this was reported 
With Scedosporinm prolijicans infection, there is 
usually a relentless progression of disease to death, despite 
treatment [7,8,10-13,15-22,36,39,43,45]. Ampho- 
tericin B was used in 28 cases [7,8,10,11,13,15-l8,20, 
22,36,39,43,45], itraconazole in seven [ 10,12,17,18, 
211, 5-flucytosine in four [7], fluconazole in seven 
[7,18,43,45] and miconazole in two [7,8]. 
Only three immunocompromised patients with 
disseminated infection with Scedosporium prolijicans have 
been reported as surviving [7,17,43]. The first had 
chronic neutropenia due to aplastic anaemia [7]. He 
presented with esophagitis, and had hepatic and splenic 
lesions. Scedosporium prolijicans was isolated from 
esophageal specimens only. The infection responded to 
a combination of amphotericin B, 5-flucytosine, 
miconazole and fluconazole. However, it is doubtful 
whether he truly had a disseminated infection, as the 
fungus was not isolated from dl sites of infection. The 
second survivor had neutropenia consequent to chemo- 
therapy for AML [17]. She received amphotericin B 
and itraconazole, the neutropenia resolved (she received 
G-CSF), and the infection cleared. Despite a leukemic 
relapse, there was no evident recurrence of Scedosporium 
prolijcans infection. The third survivor was an acute 
leukemia patient whose Scedosporium prol&ans infection 
was treated with amphotericin B and fluconazole. This 
infection also cleared once the neutropenia had 
resolved [43]. Two months later, he presented with a 
rib lump following the resolution of a further neutro- 
penic episode. The rib lesion was excised and the 
patient recovered. Scedosporium prolijicans was isolated 
from bone. These cases suggest that resolution of the 
underlying neutropenia is a prerequisite for survival 
from disseminated infection with Scedosporium prol@ans. 
In 33 cases where blood cultures were taken, 25 
were positive for the presence of Scedosporium prolijicans 
[7,8,10-13,15-22,36,39,43,45]. The BACTEC system 
[7,8,10-13,15,18-20,36,39]. 
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was used in six cases [11,15,17]. This system did not 
signal in one reported case [ 111. The BACTEC system 
is slower to signal the growth of Scedosporium prolijicans 
than the Isolator system [11,43]. With our cases 2 and 
3, the VITAL machine did not recognize growth of the 
fungus in the blood culture bottles. The microbiologist 
consulted in the cases ordered the contents of the 
bottles to be Gram stained, and this revealed hyphae 
with conidia suggestive of Scedosporium prolijicans. This 
system has recently been reported to signal unreliably 
with filamentous fungi [49]. 
Scedosporium prolijicans was isolated from CSF in 
five cases [7,12,13,21]. In two of these, it seemed likely 
that the fungus was instilled by a previous lumbar 
puncture [12,21], and in the others, meningo- 
encephalitis was probably a consequence of a systemic 
infection. 
Skin lesions were culture positive in seven cases 
[16-18,36,39,43]. In case 3, a skin aspirate prepared 
with Blankophor’s stain revealed fungal hyphae, and 
subsequently Scedosporium prolijicans was cultured from 
this sample. 
Scedosporium prolijicans is an opportunistic pathogen, 
probably acquired from the environment, most likely 
through inhalation. Scedosporium prolijicans is found in 
soil [3], including that of potted plants in a hospital [2]. 
The prominence of the pulmonary lesions is also 
suggestive of airborne infection. The four Spanish cases 
which coincided with building works support this 
mode of transmission, although no air sampling was 
performed to confirm this [l 11. Outbreaks of Aspergillus 
spp. are well described in relation to hospital con- 
struction work or contaminated air-conditioning 
systems [50]. In our unit, certain problems and 
deficiencies, outlined in the Results section, may have 
favored fungal growth, with clogged HEPA filters and 
a leaking flue resulting in the rotting and subsequent 
collapse of the ceiling. However, Scedosporium prolijicans 
was not isolated from the air within the hospital, despite 
repeated sampling. 
Reported antifungal sensitivities of isolates from a 
number of cases of Scedosporium prolijicans infection 
(including our cases 2, 3 and 4) are presented in Table 
3. 
Although antifungal susceptibility testing is not 
standardized in these studies, the results correlate with 
the observed poor clinical responses [1,3,4,7-9,11, 
14-21,34,35,43,51]. Case 2 demonstrated that high- 
dose liposomal amphotericin B is also ineffective. MICs 
for the new antifungals voriconazole [51] and serta- 
conazole [34] are somewhat lower than those of 
currently available antifungals, and these agents may be 
useful in treating disseminated infection with Scedo- 
sporium prolijicans. 
The autopsy findings in cases 1,2,  and 3 were quite 
similar to each other and similar to the cases described 
in the literature. Dissemination with fungal invasion of 
most tissues with multiple abscesses is generally found 
[7,11-13,15,18-21,431. Mycetoma are often found in 
the lungs. There is aneurysm formation in many 
organs. Microscopic examination reveals more extensive 
fungal infiltration than is evident macroscopically. 
Invasion of small and medium-sized arterioles is 
prominent, with subsequent thrombosis and infarction. 
In case 2, mycotic aneurysms were also found in the 
cerebral circulation. Hyphae with visible conidiation 
suggestive of Scedosporium prolijicans were seen in the 
tissues from eight cases [l 1.15-1 8,201, including cases 
2 and 3. 
As the hospital was undergoing redevelopment 
during the entire period of this study, it was not possible 
to determine if the incidence of infection was above 
baseline for the hospital. Also, an environmental source 
of the fungus was not identified, although the leaking 
flue, the hospital reconstruction or the clogged HEPA 
filters were all potential sources of the fungus. The 
strain differentiation of isolates from cases 2, 3 and 4 by 
allozyme electrophoresis indicated that they were 
genetically distinct, and it is improbable that a 
Scedosporium prolificarts epidemic occurred in our 
hospital. Interestingly, the isolates from the Spanish 
outbreak have been typed (by random amplification of 
polymorphic DNA and PCR fingerprinting with the 
core sequence of phage M13 as a single primer), and 
only strains from two of four patients appeared to be 
related [52], supporting our observation that infection 
with Scedosporium prolijicans is opportunistic. Further- 
more, the CSF and blood isolates from case 2 and the 
skin and blood isolates from case 3 were genetically 
distinct by allozyme analysis, indicating the possibility 
that patients can be infected by more than one strain 
simultaneously. It is interesting to note the apparent 
correlations between the genetic clusters that the 
isolates grouped into and the clinical observations of 
the Scedosporium prolijicans infection in the present 
study; namely, cases 2 and 3 both had acute myeloid 
lymphoma and were infected with Scedosporium prollficans 
in 1996, whereas case 4 had non-Hodgkin’s lymphoma 
and was infected in 1997. Further comprehensive 
genetic analyses on a broader range of isolates are 
required to assess the significance of the variation 
detected. 
Our four cases illustrate some of the clinical, 
pathologic and epidemiologic features of infection with 
Scedosporium prolijicans, an emerging fungal pathogen. 
Colonization without invasion can occur. However, in 
neutropenic patients, dissemination usually occurs, and 
is often fatal. The infection has been shown to be 
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unresponsive to all available antifungals, including 
liposomal amphotericin B. Multiple strains of Scedo- 
sporium prolijficuns may infect a patient simultaneously. 
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